MyndTec Inc. Completes Non-Brokered Private Placement
January 13, 2023

Not for distribution to U.S. news wire services or dissemination in the United States. Mississauga, Ontario, January 11, 2023 – MyndTec Inc. (“MyndTec” or the...

MyndTec Inc. Announces Non-Brokered Private Placement
November 9, 2022

Mississauga, Ontario, November 9, 2022, – – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging leader in neurological treatment and rehabilitation, is pleased...

MyndTec Announces the North American Launch of its Innovative Foot Drop FES Device MyndStep™
November 2, 2022

MyndStep™ is designed to improve mobility by providing functional electrical stimulation (FES) treatment to patients suffering from foot drop. Mississauga, Ontario, November 2, 2022, –...

MyndTec Announces Exclusive Supply and Distribution Agreement for Innovative Foot Drop FES Device MyndStep™ across the US and Canada
August 5, 2022

MyndStep™ is designed to provide functional electric stimulation (FES) treatment to patients suffering from foot drop and improve walking ability. Highlights: MyndTec expands its FES...

MyndTec Announces Board Changes
May 11, 2022

William (Bill) Jackson, a well-rounded medical device and healthcare entrepreneur joins MyndTec’s Board of Directors Mississauga, Ontario, May 11, 2022 – MyndTec Inc. (“MyndTec” or...

MyndTec Announces Investor Relations Agreement with Venture North Capital
May 3, 2022

Mississauga, Ontario, May 3, 2022 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging leader in neurological rehabilitation, is pleased to announce that...

Fourier Intelligence Inks Strategic Alliance Partnership with MyndTec Inc.
March 23, 2022

The award-winning Canadian MyndMove™ therapy from MyndTec. Inc joins SoftBankbacked rehab robotics leader Fourier Intelligence’s network of partners SINGAPORE, March 22nd, 2022 – Fourier Intelligence...

MyndTec Announces Resignation of Director
March 8, 2022

Mississauga, Ontario, March 8, 2022 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging trailblazer in neurological rehabilitation, today announced that Christine Ozimek...

MyndTec Receives FDA 510(k) Clearance for MyndMove 2.0, its Second Generation Neuromodulation Device, for Clinical and Home Use
March 8, 2022

Mississauga, Ontario, March 8, 2022 – MyndTec Inc. (“MyndTec” or the “Company”) (CSE: MYTC), an emerging trailblazer in neurological rehabilitation, today announced that it has...

Ownership of Milos and Kathrin Popovic in MyndTec Inc.
February 24, 2022

Toronto, Canada – February 24, 2022 – MyndTec Inc. (MyndTec or Company) filed and received a receipt for its final non-offering prospectus (the Prospectus) from...

Ownership of James Anderson in MyndTec Inc.
February 24, 2022

Toronto, Canada – February 24, 2022 – MyndTec Inc. (MyndTec or the Company) filed and received a receipt for its final prospectus (the Prospectus) from...

MYNDTEC INC. ANNOUNCES CLOSING OF DISTRIBUTION OF SECURITIES ISSUABLE UPON CONVERSION OF SUBSCRIPTION RECEIPTS AND LISTING ON CSE
February 24, 2022

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. MISSISSAUGA, ONTARIO February 24, 2022 — MyndTec Inc. (“MyndTec” or the...

Ownership of Peter Harvey Griggs in MyndTec Inc.
February 24, 2022

Toronto, Canada – February 24, 2022 – MyndTec Inc. (MyndTec or the Company) filed and received a receipt for its final non-offering prospectus (the Prospectus)...

MyndTec Inc. Files Final Prospectus and Receives Conditional Listing Approval from the Canadian Securities Exchange
February 16, 2022

Mississauga, Ontario (Newsfile Corp. – February 16, 2022) – MyndTec Inc. (“MyndTec” or the “Company”) is pleased to announce that it has filed and received...